![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Background:
The cost of diabetes medications and supplies is rising, resulting in access challenges. This study assessed the prevalence of and factors predicting underground exchange activities—donating, trading, borrowing, and purchasing diabetes medications and supplies.
Research Design and Methods:
A convenience sample of people affected by diabetes was recruited online to complete a survey. Mixed method analysis was undertaken, including logistic regression to examine the relationship between self-reported difficulty purchasing diabetes medications and supplies and engagement in underground exchange activity. Thematic qualitative analysis was used to examine open-text responses.
Results:
Participants (N = 159) self-reported engagement in underground exchange activities, including donating (56.6%), donation receiving (34.6%), trading (23.9%), purchasing (15.1%), and borrowing (22%). Such activity took place among a variety of individuals, including friends, family, coworkers, online acquaintances and strangers. Diabetes-specific financial stress predicted engagement in trading diabetes mediations or supplies (OR 6.3, 95% CI 2.2-18.5) and receiving donated medications or supplies (OR 2.8, 95% CI 1.1-7.2). One overarching theme, unmet needs, and three subthemes emerged: (1) factors influencing underground exchange activity, (2) perceived benefits of underground exchange activity, and (3) perceived consequences of underground exchange activity.
Conclusion:
Over half of the participants in this study engaged in underground exchange activities out of necessity. Providers must be aware about this underground exchange and inquire about safety and possible alternative resources. There is an urgent need to improve access to medications that are essential for life. Our study points to a failure in the US healthcare system since such underground exchanges may not be necessary if medications and supplies were accessible.
References
| 1. |
Biniek, JF, Johnson, W. Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices. Health Care Cost Institute. 2019. https://healthcostinstitute.org/images/easyblog_articles/267/HCCI-Insulin-Use-and-Spending-Trends-Brief-01.22.19.pdf. Google Scholar |
| 2. |
Cefalu, WT, Dawes, DE, Gavlak, G, et al. Insulin access and affordability working group: conclusions and recommendations. Diabetes Care. 2018;41(6):1299-1311. Google Scholar | Crossref | Medline |
| 3. |
Berchick, ER, Hood, E, Barnett, JC. Current Population Reports, P60-264, Health Insurance Coverage in the United States: 2017. Washington, DC: U.S. Government Printing Office; 2018. Google Scholar |
| 4. |
Herkert, DM, Vijayakumar, P, Luo, J, et al. Cost-related insulin underuse is common and associated with poor glycemic control. Diabetes. 2018; 67(Suppl1). Google Scholar | Crossref |
| 5. |
Sable-Smith, B . Insulin’s high cost leads to lethal rationing. NPR. https://www.npr.org/sections/health-shots/2018/09/01/641615877/insulins-high-cost-leads-to-lethal-rationing. Accessed September 1, 2018. Google Scholar |
| 6. |
Konrad, W . Black market insulin: what you need to know. https://www.cbsnews.com/news/black-market-insulin-what-you-need-to-know/. Accessed June 20, 2017. Google Scholar |
| 7. |
Mullard, A. Underground drug networks in the early days of AIDS. Lancet. 2014;383(9917):592. Google Scholar | Crossref |
| 8. |
Vernaz-Hegi, N, Calmy, A, Hurst, S, et al. A buyers’ club to improve access to hepatitis C treatment for vulnerable populations. Swiss Med Wkly. 2018;148:w14649. Google Scholar | Medline |
| 9. |
Adriance, S. Fighting for the ‘right to try’ unapproved drugs: law as persuasion. Yale LJF. 2014;124:148. Google Scholar |
| 10. |
Litchman, ML, Walker, HR, Ng, AH, et al. State of the science: a scoping review and gap analysis of diabetes online communities. J Diabetes Sci Technol. 2019;13(3):466-492. Google Scholar | SAGE Journals |
| 11. |
Hilliard, ME, Sparling, KM, Hitchcock, J, Oser, TK, Hood, KK. The emerging diabetes online community. Curr Diabetes Rev. 2015;11(4):261-272. Google Scholar | Crossref | Medline | ISI |
| 12. |
Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. Google Scholar | Crossref | Medline | ISI |
| 13. |
Prawitz, A, Garman, ET, Sorhaindo, B, O’Neill, B, Kim, J, Drentea, P. Incharge financial distress/financial well-being scale: development, administration, and score interpretation. Financ Couns Plan. 2006;17(1):34-50. Google Scholar |
| 14. |
Morgan, DL. Qualitative content analysis: a guide to paths not taken. Qual Health Res. 1993;3(1):112-121. Google Scholar | SAGE Journals |
| 15. |
Sandelowski, M. Focus on research methods: whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334-340. Google Scholar | Crossref | Medline | ISI |
| 16. |
Tesch, R. Qualitative Research: Analysis Types and Software Tools. New York, NY: Psychology Press; 1990. Google Scholar |
| 17. |
Morse, JM. The Significance of Saturation. Thousand Oaks, CA: Sage Publications; 1995. Google Scholar | SAGE Journals |
| 18. |
Penchansky, R, Thomas, JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19(2):127-140. Google Scholar | Crossref | Medline | ISI |
| 19. |
Saurman, E. Improving access: modifying Penchansky and Thomas’s Theory of Access. J Health Serv Res Policy. 2016;21(1):36-39. Google Scholar | SAGE Journals | ISI |
| 20. |
Beyene, K, Aspden, T, Sheridan, J. Prescription medicine sharing: exploring patients’ beliefs and experiences. J Pharm Policy Pract. 2016;9(1):23. Google Scholar | Crossref | Medline |
| 21. |
Beyene, K, Aspden, T, Sheridan, J. Prevalence and predictors of medicine saving and future prescription medicine sharing: findings from a New Zealand online survey. Int J Pharm Pract. 2019;27(2):166-174. Google Scholar | Crossref | Medline |
| 22. |
Beyene, KA, Aspden, TJ, Sheridan, JL. A qualitative exploration of healthcare providers’ perspectives on patients’ non-recreational, prescription medicines sharing behaviours. J Pharm Pract Res. 2018;48(2):158-166. Google Scholar | Crossref |
| 23. |
Onisie, O, Crocket, H, de Bock, M. The CGM grey market: a reflection of global access inequity. Lancet Diabetes Endocrinol. 2019;7(11):823-825. Google Scholar | Crossref | Medline |
| 24. |
Cauchi, R, Berg, K. State Prescription Drug Return, Reuse and Recycling Laws. 2018. http://www.ncsl.org/research/health/state-prescription-drug-return-reuse-and-recycling.aspx. Accessed June 7, 2019. Google Scholar |
| 25. |
Owens, DR, Traylor, L, Mullins, P, Landgraf, W. Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100 U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy. Diabetes Res Clin Pract. 2017;124:57-65. Google Scholar | Crossref | Medline |
| 26. |
Lipska, KJ, Parker, MM, Moffet, HH, Huang, ES, Karter, AJ. Association of initiation of basal insulin analogs vs neutral protamine hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes. JAMA. 2018;320(1):53-62. Google Scholar | Crossref | Medline |
| 27. |
Strandberg, AY, Khanfir, H, Makimattila, S, Saukkonen, T, Strandberg, TE, Hoti, F. Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults. Ann Med. 2017;49(4):357-364. Google Scholar | Crossref | Medline |
| 28. |
Kristensen, PL, Tarnow, L, Bay, C, et al. Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with type 1 diabetes. Diabet Med. 2017;34(5):625-631. Google Scholar | Crossref | Medline |
| 29. |
Flores, NM, Patel, CA, Bookhart, BK, Bacchus, S. Consequences of non-medical switch among patients with type 2 diabetes. Curr Med Res Opin. 2018;34(8):1475-1481. Google Scholar | Crossref | Medline |
| 30. |
Beyene, KA, Sheridan, J, Aspden, T. Prescription medication sharing: a systematic review of the literature. Am J Public Health. 2014;104(4):e15-e26. Google Scholar | Crossref | Medline |
| 31. |
Rogers, MAM, Lee, JM, Tipirneni, R, Banerjee, T, Kim, C. Interruptions in private health insurance and outcomes in adults with type 1 diabetes: a longitudinal study. Health Aff. 2018;37(7):1024-1032. Google Scholar | Crossref |
| 32. |
Gaffney, A, Christopher, A, Katz, A, et al. The incidence of diabetic ketoacidosis during “emerging adulthood” in the USA and Canada: a population-based study. J Gen Intern Med. 2019;34(7):1244-1250. Google Scholar | Crossref | Medline |
